breakthrough therapy
Entity, reached from Hormuz.
- Evidence
- 54 documents · 19 separate publishers
- Standing
- Added automatically from coverage
- Time
- first seen 25 Jun 2026, last seen 9 Oct 2026
- Measured
- 50% of mentions say something specific about it; the rest only name it
- As of
- 10 Oct 2026
Where this comes from
- PR Newswire · 2026-10-07 · AbbVie's Telisotuzumab Adizutecan (Temab-A) Receives Two Breakthrough Therapy Designations From the U.S. FDA for CRC and NSCLC (opens the source in a new tab)
- AllSci News · 2026-09-30 · Alume wins FDA Breakthrough Therapy Designation for nerve-visualization agent bevonescein (opens the source in a new tab)
- The Clinical Trial Vanguard · 2026-09-24 · FDA Approves Lyrfigtu for FGFR2-Rearranged Cholangiocarcinoma (opens the source in a new tab)
What is claimed about it
Situations it is named in
Who it moves with
- co-mentioned with fda (50 documents)seen together
- co-mentioned with drug administration (19 documents)seen together
- co-mentioned with orphan drug (15 documents)seen together
- co-mentioned with adverse events (15 documents)seen together
- co-mentioned with china (13 documents)seen together
- co-mentioned with clinical trials (13 documents)seen together
- co-mentioned with fda-approved (12 documents)seen together
- co-mentioned with priority review (12 documents)seen together
- co-mentioned with nasdaq (11 documents)seen together
- co-mentioned with lung cancer (9 documents)seen together